Tod was Chief Scientific Officer at Hexagon Bio, and Chief Scientific Officer of Cancer Biology, Oncology Research at Eli Lilly. Tod Smeal joined Cardiff Oncology in 2022.
Tod Smeal is currently
Create your alert
to follow the career of Tod Smeal.
Tod Smeal has a PhD in Biology from University of California, San Diego and a post-doctoral from Massachusetts Institute of Technology.
They have also studied at University of California, San Diego :
Find more alumni from University of California, San Diego
They have also studied at Massachusetts Institute of Technology :
Find more alumni from Massachusetts Institute of Technology
Do you need to know more about Tod Smeal? More results.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.